Kuros Biosciences Ltd. (CSBTF)
26.99
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Kuros Biosciences Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2013 | 45.54M |
| September 30, 2013 | 18.55M |
| June 30, 2013 | 20.80M |
| March 31, 2013 | 26.74M |
| December 31, 2012 | 33.20M |
| September 30, 2012 | 38.09M |
| June 30, 2012 | 39.99M |
| March 31, 2012 | 10.28M |
| December 31, 2011 | 32.95M |
| September 30, 2011 | 42.69M |
| June 30, 2011 | 51.22M |
| March 31, 2011 | 53.07M |
| December 31, 2010 | 58.01M |
| September 30, 2010 | 61.02M |
| June 30, 2010 | 59.47M |
| March 31, 2010 | 53.66M |
| December 31, 2009 | 66.46M |
| September 30, 2009 | 77.30M |
| June 30, 2009 | 80.70M |
| March 31, 2009 | 87.05M |
| December 31, 2008 | 104.06M |
| September 30, 2008 | 97.29M |
| June 30, 2008 | 105.64M |
| Date | Value |
|---|---|
| March 31, 2008 | 114.12M |
| December 31, 2007 | 109.14M |
| September 30, 2007 | 113.16M |
| June 30, 2007 | 116.50M |
| March 31, 2007 | 97.23M |
| December 31, 2006 | 47.03M |
| September 30, 2006 | 50.65M |
| June 30, 2006 | 56.06M |
| March 31, 2006 | 58.38M |
| December 31, 2005 | |
| September 30, 2005 | |
| June 30, 2005 | |
| March 31, 2005 | |
| December 31, 2004 | 78.34M |
| September 30, 2004 | 76.97M |
| June 30, 2004 | 80.65M |
| March 31, 2004 | 86.57M |
| December 31, 2003 | 65.60M |
| September 30, 2003 | 62.28M |
| June 30, 2003 | 64.41M |
| March 31, 2003 | 72.06M |
| December 31, 2002 | |
| September 30, 2002 | 46.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Molecular Partners AG | 93.84M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 9.176B |
| AC Immune SA | 186.45M |